Z-338 Phase III Trial - Evaluation of Pharmacokinetics, Efficacy and Safety in Paediatric Patients With Functional Dyspepsia
Latest Information Update: 27 Jul 2026
At a glance
- Drugs Acotiamide (Primary)
- Indications Non-ulcer dyspepsia
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors Zeria
Most Recent Events
- 24 Jul 2026 Status changed from active, no longer recruiting to completed.
- 18 Mar 2026 Status changed from recruiting to active, no longer recruiting.
- 03 Jul 2024 Planned End Date changed from 1 Apr 2025 to 1 Jun 2026.